Athersys Stock Price

-0.0058 (-2.31%)
Upgrade to Real-Time
Regular Market
Volume 1,445,466
Bid Price 0.2433
Ask Price 0.245
News -
Day High 0.25


52 Week Range


Day Low 0.2449
Company Name Stock Ticker Symbol Market Type
Athersys Inc ATHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0058 -2.31% 0.245 09:45:39
Open Price Low Price High Price Close Price Prev Close
0.25 0.2449 0.25 0.2508
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,663 1,445,466 $ 0.2486179 $ 359,369 - 0.1708 - 1.81
Last Trade Time Type Quantity Stock Price Currency
09:45:43 10 $ 0.245 USD


Draw Mode:

Athersys Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 64.66M 263.93M 246.85M $ 5.51M $ - -0.39 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 57.89k 1.70%

more financials information »

Athersys News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATHX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.29280.2950.23180.26752976,147,162-0.0478-16.33%
1 Month0.20420.3880.17080.29464823,475,1780.040819.98%
3 Months0.21550.420.17080.285828112,958,0160.029513.69%
6 Months0.89971.330.17080.35403978,040,039-0.6547-72.77%
1 Year1.641.810.17080.48683164,744,732-1.40-85.06%
3 Years1.254.420.17081.343,120,605-1.01-80.4%
5 Years1.704.420.17081.412,172,250-1.46-85.59%

Athersys Description

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now